Ayson, Ar-jay D.

HRN: 21-12-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFTRIAXONE 1G (VIAL)
09/18/2022
09/25/2022
IVTT
500mg
Q12
Typhoid, Pcap
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: